Sangeetha Venugopal, MD, MS, discusses how measurable residual disease is used during the course of treatment of AML.
Sangeetha Venugopal, MD, MS
Sangeetha Venugopal, MD, MS, is a physician in the Department of Medicine, Division of Hematology, at the Sylvester Comprehensive Cancer Center at the University of Miami.
Articles by Sangeetha Venugopal, MD, MS
Sangeetha Venugopal, MD, MS, discusses the dynamic landscape of molecular targets in acute myeloid leukemia.
Sangeetha Venugopal, MD, MS, discusses what she is most interested about regarding unmet needs in patients with AML.
Sangeetha Venugopal, MD, MS, discusses the evolving field of acute myeloid leukemia treatment.